MARKSANS PHARMA LTD. - 524404 - Announcement under Regulation 30 (LODR)-Allotment
The Board of Directors at its meeting held today, i.e., 23rd July, 2021, has created, issued and allotted 5,03,24,324 convertible warrants on preferential basis. MARKSANS PHARMA LTD. - 524404 - Shareholding for the Period Ended June 30, 2021
Marksans Pharma Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2021. For more details, kindly Click here Marksans Pharma Ltd - 524404 - Board Meeting Intimation for Notice Of Board Meeting
MARKSANS PHARMA LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/07/2021 ,inter alia, to consider and approve allotment of convertible warrants on preferential basis. MARKSANS PHARMA LTD. - 524404 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Please find enclosed herewith a Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 30th June, 2021 received from Bigshare Services Private Limited, Registrar and Transfer Agent of the Company. MARKSANS PHARMA LTD. - 524404 - Statement Of Investor Complaints For The Quarter Ended June 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Harshavardhan PanigrahiDesignation :- Company Secretary and Compliance Officer Marksans Pharma Ltd - 524404 - Disclosure of Voting results of EGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Marksans Pharma Ltd has informed BSE regarding the details of Voting results of EGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here Marksans Pharma Ltd - 524404 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Enclosed herewith kindly find a News Release dated 9th July, 2021 of the Company. Marksans Pharma Ltd - 524404 - Scrutinizer''s Report
Please find enclosed herewith the results of the voting conducted through remote e-voting during 6th July, 2021 to 8th July, 2021 (both days inclusive) and through e-voting during the EGM of Marksans Pharma Limited held on 9th July, 2021 through video conferencing along with Consolidated report of the Scrutinizer. Marksans Pharma Ltd - 524404 - Outcome Of The Extra-Ordinary General Meeting Held On Friday, 9Th July, 2021
Outcome of the Extra-ordinary General Meeting held on Friday, 9th July, 2021. Marksans Pharma Ltd - 524404 - Proceedings Of The Extra-Ordinary General Meeting Of Marksans Pharma Limited Held On Friday, July 9, 2021 Through Video Conferencing.
Proceedings of the Extra-ordinary General Meeting of Marksans Pharma Limited held on Friday, July 9, 2021 through Video Conferencing.